相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Normalization of TAM post-receptor signaling reveals a cell invasive signature for Axl tyrosine kinase
Stanley G. Kimani et al.
CELL COMMUNICATION AND SIGNALING (2016)
4-Oxo-1,4-dihydroquinoline-3-carboxamide Derivatives as New Axl Kinase Inhibitors
Li Tan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Resensitization to Crizotinib by the Lorlatinib ALK Resistance Mutation L1198F
Alice T. Shaw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
State-of-the-art of small molecule inhibitors of the TAM family: The point of view of the chemist
Tom Baladi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
MET and AXL Inhibitor NPS-1034 Exerts Efficacy against Lung Cancer Cells Resistant to EGFR Kinase Inhibitors Because of MET or AXL Activation
Jin Kyung Rho et al.
CANCER RESEARCH (2014)
Discovery of (10R)-7-Amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]-benzoxadiazacyclotetradecine-3-carbonitrile (PF-06463922), a Macrocyclic Inhibitor of Anaplastic Lymphoma Kinase (ALK) and c-ros Oncogene 1 (ROS1) with Preclinical Brain Exposure and Broad-Spectrum Potency against ALK-Resistant Mutations
Ted W. Johnson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Axl Kinase as a Key Target for Oncology: Focus on Small Molecule Inhibitors
Clemence Feneyrolles et al.
MOLECULAR CANCER THERAPEUTICS (2014)
AXL kinase as a novel target for cancer therapy
Xiaoliang Wu et al.
ONCOTARGET (2014)
Differential TAM receptor-ligand-phospholipid interactions delimit differential TAM bioactivities
Erin D. Lew et al.
ELIFE (2014)
The TAM family: phosphatidylserine-sensing receptor tyrosine kinases gone awry in cancer
Douglas K. Graham et al.
NATURE REVIEWS CANCER (2014)
Discovery of 1-[3-(1-Methyl-1H-pyrazol-4-y1)-5-oxo-5H-benzo[4,5]cyclohepta[1,2-b]pyridin-7-yl]-N-(pyridin-2-ylmethyl)methanesulfonamide (MK-8033): A Specific c-Met/Ron Dual Kinase Inhibitor with Preferential Affinity for the Activated State of c-Met
Alan B. Northrup et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
iPS cells in humans
David Cyranoski
NATURE BIOTECHNOLOGY (2013)
Biology of the TAM Receptors
Greg Lemke
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
Novel and selective spiroindoline-based inhibitors of sky kinase
Noel A. Powell et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer
Zhenfeng Zhang et al.
NATURE GENETICS (2012)
Discovery of Small Molecule Mer Kinase Inhibitors for the Treatment of Pediatric Acute Lymphoblastic Leukemia
Jing Liu et al.
ACS MEDICINAL CHEMISTRY LETTERS (2012)
Structural Basis for Selective Small Molecule Kinase Inhibition of Activated c-Met
Keith W. Rickert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Targeting Axl and Mer Kinases in Cancer
Anupam Verma et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Design, Synthesis, and Biological Evaluation of a Series of Novel AXL Kinase Inhibitors
Alexis Mollard et al.
ACS MEDICINAL CHEMISTRY LETTERS (2011)
Features and development of Coot
P. Emsley et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)
The Crystal Structure of a Constitutively Active Mutant RON Kinase Suggests an Intramolecular Autophosphorylation Hypothesis
Jing Wang et al.
BIOCHEMISTRY (2010)
Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival
Christine Gjerdrum et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Enzymatic Characterization of c-Met Receptor Tyrosine Kinase Oncogenic Mutants and Kinetic Studies with Aminopyridine and Triazolopyrazine Inhibitors
Sergei L. Timofeevski et al.
BIOCHEMISTRY (2009)
The Axl receptor tyrosine kinase confers an adverse prognostic influence in pancreatic cancer and represents a new therapeutic target
Jan-Bart M. Koorstra et al.
CANCER BIOLOGY & THERAPY (2009)
Novel Mechanism of Lapatinib Resistance in HER2-Positive Breast Tumor Cells: Activation of AXL
Li Liu et al.
CANCER RESEARCH (2009)
Mechanism for Activation of the EGF Receptor Catalytic Domain by the Juxtamembrane Segment
Natalia Jura et al.
CELL (2009)
Cytoplasmic ACK1 Interaction with Multiple Receptor Tyrosine Kinases Is Mediated by Grb2 AN ANALYSIS OF ACK1 EFFECTS ON Axl SIGNALING
Lin Pao-Chun et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Structural insights into the inhibited states of the Mer receptor tyrosine kinase
Xudong Huang et al.
JOURNAL OF STRUCTURAL BIOLOGY (2009)
The Juxtamembrane Region of the EGF Receptor Functions as an Activation Domain
Monica Red Brewer et al.
MOLECULAR CELL (2009)
Receptor tyrosine kinase AXL is induced by chemotherapy drugs and overexpression of AXL confers drug resistance in acute myeloid leukemia
Chih-Chen Hong et al.
CANCER LETTERS (2008)
Axl and growth arrest - Specific gene 6 are frequently overexpressed in human gliomas and predict poor prognosis in patients with glioblastoma multiforme
Markus Hutterer et al.
CLINICAL CANCER RESEARCH (2008)
Immunobiology of the TAM receptors
Greg Lemke et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Phaser crystallographic software
Airlie J. McCoy et al.
JOURNAL OF APPLIED CRYSTALLOGRAPHY (2007)
A novel tyrosine kinase switch is a mechanism of imatinib resistance in gastrointestinal stromal tumors
D. Mahadevan et al.
ONCOGENE (2007)
A change in conformational dynamics underlies the activation of Eph receptor tyrosine kinases
Silke Wiesner et al.
EMBO JOURNAL (2006)
TAM receptor function in the retinal pigment epithelium
Dipti Prasad et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2006)
Phosphatidylserine recognition by phagocytes: a view to a kill
Y Wu et al.
TRENDS IN CELL BIOLOGY (2006)
Structural basis for Gas6-Axl signalling
T Sasaki et al.
EMBO JOURNAL (2006)
Determination of accurate KI values for tight-binding enzyme inhibitors:: an in silico study of experimental error and assay design
DJ Murphy
ANALYTICAL BIOCHEMISTRY (2004)
Ligand recognition and homophilic interactions in Tyro3 -: Structural insights into the Axl/Tyro3 receptor tyrosine kinase family
C Heiring et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Regulation of protein kinases: Controlling activity through activation segment conformation
B Nolen et al.
MOLECULAR CELL (2004)
Juxtamembrane autoinhibition in receptor tyrosine kinases
SR Hubbard
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)
The protein kinase complement of the human genome
G Manning et al.
SCIENCE (2002)
The conformational plasticity of protein kinases
M Huse et al.
CELL (2002)
Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family
QX Lu et al.
SCIENCE (2001)
Phagocytosis and clearance of apoptotic cells is mediated by MER
RS Scott et al.
NATURE (2001)
Mutations in MERTK, the human orthologue of the RCS rat retinal dystrophy gene, cause retinitis pigmentosa
A Gal et al.
NATURE GENETICS (2000)